UNIGE document Scientific Article
previous document  unige:89823  next document
add to browser collection
Title

Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccine

Authors
Chehade, Hassib
Rudin, Christoph
Published in Vaccine. 2016, vol. 34, no. 41, p. 4948-4954
Abstract Infections are among the main life-threatening complications in patients with nephrotic syndrome (NS), in particular with Streptococcus pneumoniae, the first cause of bacterial peritonitis and sepsis in these patients. This study aims to evaluate the baseline seroprotection of NS patients against S. pneumoniae, and immunize them with the 13-valent pneumococcal conjugate vaccine (PCV13) regardless of disease activity and previous immunization history, in order to evaluate the immunogenicity, safety profile, and effect of NS treatment on vaccine responses.
Identifiers
PMID: 27576076
Full text
Article (Published version) (901 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Groupe Posfay-Barbe Clara (pédiatrie générale) (853)
Citation
(ISO format)
PITTET, Laure et al. Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccine. In: Vaccine, 2016, vol. 34, n° 41, p. 4948-4954. https://archive-ouverte.unige.ch/unige:89823

58 hits

1 download

Update

Deposited on : 2016-12-02

Export document
Format :
Citation style :